冲击组对心脏性冲击患者短期结果的有效性 - 系统性审查和元分析
Marina Arai1, Toru Kondo2, Takahiro Nakashima3
1Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine Sendai Japan.
Circulation reports
|January 12, 2026
概括
由心脏性休克 (CS) 团队进行的管理可能会减少短期死亡率和出血. 然而,证据很少,需要进一步的前性研究来确认好处和优化团队角色.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 心脏性休克 (CS) 是一种需要特殊护理的危急状况.
- 冲击团队已经出现,以加强CS管理,但其有效性尚未得到充分证明.
研究的目的:
- 系统地审查和对现有研究进行元分析,以确定冲击团队管理是否能改善CS患者的结果.
主要方法:
- 以PRISMA为指导的系统审查和对比CS患者的研究的元分析,这些患者与或没有冲击团队一起管理.
- 搜索了PubMed,科学网和科克兰图书馆的数据库.
- 主要结局:短期死亡率;次要结局:出血.
主要成果:
- 对3项回顾性队列研究 (确定7项) 的分析表明,冲击团队管理与显著较低的短期死亡率 (OR 0.52) 和出血 (OR 0.62) 相关.
- 敏感性分析证实了对死亡率的好处.
- 由于存在偏见和不一致的风险,证据确定性被评为非常低,不包括随机试验.
结论:
- 冲击团队管理可能有利于心脏性冲击的短期结果.
- 目前的证据水平非常低,需要进一步进行高质量的前性研究.
- 未来的研究应该专注于最佳的冲击队组成和特定的角色.
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
635
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
635
Blood Pressure Imbalances and Circulatory Shock
1.5K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.5K
Cardiopulmonary Resuscitation III: AED Use
512
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
512
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
909
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
909
Acute Coronary Syndrome IV: Interprofessional Care
211
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
211
Heart Failure V: Medical Management
208
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
208


